niedziela, 31 października 2021

FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk, company says - The Washington Post

FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk, company says  The Washington PostView Full Coverage on Google News

from Top stories - Google News https://ift.tt/2ZGFo8n
via gqrds

Brak komentarzy:

Prześlij komentarz